Insight ReportElizabeth Arden (RDEN) 2Q16 Results: Misses EPS by $0.50 and Misses on Revenue Coresight Research February 4, 2016 Executive Summary Elizabeth Arden reported 2Q16 revenues of $316.2 million, a decrease of 5.2% from the year-ago quarter and missing the consensus estimate of $340.9 million. Excluding currency effects, sales were down 1%. Diluted non-GAAP EPS was $0.10, below the consensus estimate of $0.60. Sales of Elizabeth Arden branded products led growth, increasing by 3%. The growth was driven by higher fragrance and skin care sales, which increased by 8% and 2%, respectively. Management expects foreign currency headwinds to negatively impact full-year net sales growth by approximately 3.75%. In November 2015, the company had estimated a 3% negative impact. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Seasonal Shopping, 1Q26—Expectations for Valentine’s Day and Presidents’ Day: US Consumer Survey Insights ExtraWeekly US and UK Store Openings and Closures Tracker 2025, Week 9: Joann To Close an Additional 300+ Stores, Shuttering All LocationsAnalyst Corner: Decoding the Resurgence of Online Grocery Retail in the US, with Sujeet Naik2Q25 Retail Inventory Insights: Diverging Strategies Amid Tariff Impacts in the Pre-Holiday Build-Up
